SCHEMBL25300046

SCHEMBL25300046

O=C(O)C1C2C=CC(C2)C1C(=O)Nc1nc2ccc(Cl)cc2s1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.70
CASP3 P42574 6/20 0.63
SENP8 Q96LD8 6/20 0.63
SENP7 Q9BQF6 6/20 0.63
SENP6 Q9GZR1 6/20 0.63
DYRK1A Q13627 1/20 0.57
FSCN1 Q16658 1/20 0.57
CYP2D6 P10635 1/20 0.57
CYP2B6 P20813 1/20 0.57
CYP2C19 P33261 1/20 0.57
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
NPC1 O15118 3/20 0.55
RAB9A P51151 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
CLK1 P49759 1/20 0.55
PTPN1 P18031 1/20 0.52
TDP1 Q9NUW8 1/20 0.50
CNR2 P34972 1/20 0.49
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30450710 1.00 ALDH1A1 (0.70) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL30450168 0.91 ALDH1A1 (0.66) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL25833484 0.91 ALDH1A1 (0.66) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL25259451 0.91 ALDH1A1 (0.66) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL25303826 0.87 ALDH1A1 (0.72) ALDH1A1DYRK1ANPC1RAB9ATDP1
SCHEMBL25833395 0.87 ALDH1A1 (0.72) ALDH1A1DYRK1ANPC1RAB9ATDP1
SCHEMBL25300443 0.86 ALDH1A1 (0.70) ALDH1A1DYRK1ACYP2C19KMT2ANPC1
SCHEMBL25299185 0.86 ALDH1A1 (0.70) ALDH1A1CASP3SENP8SENP7SENP6
SCHEMBL30451111 0.86 ALDH1A1 (0.70) ALDH1A1DYRK1ACYP2C19KMT2ANPC1
SCHEMBL25260244 0.86 ALDH1A1 (0.74) ALDH1A1DYRK1AMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250382273-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INST NAT SANTE RECH MED (FR) 2025-12-18 US claimed
WO-2023131649-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2023-07-13 WO claimed
US-20250382273-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INST NAT SANTE RECH MED (FR) 2025-12-18 US disclosed
WO-2023131649-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2023-07-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250382273-A1 BENZOTHIAZOLE ANAOLOGUES AND USE THEREOF AS BOOSTERS OF ANTI TUBERCULOSIS DRUGS BBOX1, NDUFB6, NDUFB5 ALDH1A1 108/4885CASP3 2385/4885SENP8 2681/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.